• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
CONCLUSION: The selective CatK inhibitor may prevent the establishment and progression of PCa in bone, thus making it a novel therapeutic approach for advanced PCa. PMID: 31172267 [PubMed - as supplied by publisher]
Source: Clinical Prostate Cancer - June 5, 2019 Category: Cancer & Oncology Authors: Liang W, Wang F, Chen Q, Dai J, Escara-Wilke J, Keller ET, Zimmermann J, Hong N, Lu Y, Zhang J Tags: J Cancer Res Clin Oncol Source Type: research

Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone
ConclusionThe selective CatK inhibitor may prevent the establishment and progression of PCa in bone, thus making it a novel therapeutic approach for advanced PCa.
Source: Journal of Cancer Research and Clinical Oncology - June 5, 2019 Category: Cancer & Oncology Source Type: research